HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.

Abstract
In 16 patients with critical condition due to severe heart failure associated with digitalis toxicity, the effects of potassium canrenoate (AldactoneR) administered intravenously were studied. Rhythm and conduction disturbances disappeared or improved in all instances. This effect was well correlated with an increase of serum potassium concentration. In 13 patients, after 1-2 days of Aldactone therapy, heart failure improved, which could be explained by a diuretic effect and by a possible inotropic action of aldactone. It is concluded that intravenous Aldactone is useful in patients with severe heart failure and digitalis toxicity in whom diuretics are often ineffective and even dangerous.
AuthorsR Cristodorescu, M Puschita, G Deutsch, E Berger, C Luca
JournalMedecine interne (Med Interne) 1977 Jan-Mar Vol. 15 Issue 1 Pg. 27-34 ISSN: 0377-1202 [Print] Romania
PMID841250 (Publication Type: Journal Article)
Chemical References
  • Digitalis Glycosides
  • Pregnadienes
  • Canrenoic Acid
Topics
  • Adult
  • Aged
  • Arrhythmias, Cardiac (drug therapy)
  • Canrenoic Acid (therapeutic use)
  • Digitalis Glycosides (poisoning)
  • Female
  • Heart Diseases (chemically induced, drug therapy)
  • Heart Failure (drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Pregnadienes (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: